Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
Biotechnology company Silence Therapeutics says merger discussions with an unidentified company announced in September are proceeding satisfactorily.
It expects to be able to announce details of the proposed transaction within the next few weeks.
The merger will be put to a shareholder vote at a separate EGM to be convened when all the information is available to shareholders.
Trading in the company's shares will remain suspended pending publication of an admission document containing that information.
The company's 2009 AGM will be held on Monday, 14 December
Story provided by Business Financial Newswire
BAE Systems fell this morning after a late bid for the British army's next generation Scout armoured vehicle was launched.
UBS <UBSN.VX> is considering possibly returning to its commodities busines...
© 2010 The IBTimes Company Ltd. All Rights Reserved.
Partners 
EMAIL
PRINT
RSS
SHARE
